Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Vancomycin Post

Drug Monitoring

Vancomycin PeakVancomycin Post-dose LevelVanco PeakVanco Post

Review status

Currently under review

Pending specialist review and validation.

What it shows

Vancomycin Post measures the amount of the antibiotic vancomycin in your blood shortly after a dose has been given. This is sometimes called a peak level. It helps your care team see how high the drug level rises after the infusion finishes and how your body is handling the medicine at that point.

The blood sample is drawn at a planned time after the dose to reflect how the drug has distributed in your body. This test is part of therapeutic drug monitoring for serious infections treated with vancomycin and may be paired with other measurements to guide dosing.

Why it matters

Getting vancomycin levels into the right range improves the chances of clearing difficult infections while limiting side effects. A post-dose level can show whether the dose and infusion plan are leading to adequate exposure, especially early in therapy or after changes to your regimen.

Your clinician may order this test when starting treatment, after a dose adjustment, or if you have conditions that affect how your body processes the drug, such as reduced kidney function, critical illness, or fluctuating fluid balance. Monitoring also helps lower the risk of kidney and hearing problems that can occur when levels are too high or when other risk factors are present.

Understanding your results

Your result is interpreted together with the exact timing of the blood draw, your kidney function, the severity and site of infection, and other data such as trough levels or overall drug exposure calculations. A result that is lower than the goal may suggest the dose or infusion timing needs adjustment, or that the sample was collected later than intended. A result that is higher than the goal may prompt your team to reduce the dose, extend the dosing interval, or verify that the sample timing was correct.

Do not change your dosing schedule on your own. If you notice decreased urine output, ringing in the ears, imbalance, or new dizziness, contact your care team. Follow-up testing is common, particularly if your condition changes or you start or stop other medicines.

Reference ranges

-- mg/L
All sexes
0 days – 18 years
3040 mg/L
All sexes
18 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Vancomycin Post

  • Sample timing after infusion

    If the blood is drawn too early or too late compared with the planned time after the infusion, the value can misrepresent the true post-dose level and lead to incorrect dose changes. Confirm the collection time with your care team.

  • Kidney function and hydration

    Vancomycin is cleared by the kidneys, so changes in kidney function or fluid balance can quickly shift levels. Dehydration, aggressive IV fluids, or acute illness can affect results from day to day.

  • Other medications

    Medicines that affect the kidneys or the inner ear, such as certain diuretics or aminoglycosides, can raise the risk from higher vancomycin levels. Some drugs also change vancomycin clearance.

  • Infusion rate and dose accuracy

    Rapid infusions or incorrect dose amounts can produce higher peaks and adverse reactions. Report any infusion problems, rate changes, or dose rounding to your clinical team.

  • Body size and critical illness

    Obesity, burns, sepsis, or liver disease can alter how vancomycin distributes in the body. Individualized monitoring and dose adjustments are often needed in these settings.

  • Dialysis and extracorporeal support

    Hemodialysis or continuous renal replacement therapies can remove vancomycin and change levels unpredictably. Sampling and dosing strategies differ for patients on these supports.

2026

References

  1. McGill University Health Centre. (2015, July 02). Vancomycin Post (Task CD 317818). Laboratory reference ranges.
  2. Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Maples, H. D., & Rodvold, K. A. (2020). Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review. American Journal of Health-System Pharmacy, 77(11), 835-864. External link